VivoSim Labs expects fiscal 2027 revenue growth to exceed 500% guidance
VIVS•VivoSim Labs expects fiscal 2027 revenue growth to exceed its July 15 guidance of more than 500%, citing a seven-figure testing agreement with a top-10 global pharmaceutical company.




